- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 39-53 of
234 results
2003 Exhibit: Jonathan D Rockoff, et al, FDA Approves Gileads Hepatitis C Drug TH...
Document
IPR2018-00126, No. 2003-26 Exhibit - Jonathan D Rockoff, et al, FDA Approves Gileads Hepatitis C Drug THE WALL STREET JOURNAL, 2013 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2001 Exhibit: Miriam E Tucker, FDA Approves Game Changer Hepatitis C Drug Sof...
Document
IPR2018-00126, No. 2001-24 Exhibit - Miriam E Tucker, FDA Approves Game Changer Hepatitis C Drug Sofosbuvir, MEDSCAPE, 2013 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2002 Exhibit: Andrew Pollack, FDA Approves Pill to Treat Hepatitis C, THE NEW YO...
Document
IPR2018-00126, No. 2002-25 Exhibit - Andrew Pollack, FDA Approves Pill to Treat Hepatitis C, THE NEW YORK TIMES, 2013 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2007 Exhibit: Joel Bernstein, POLYMORPHISM IN MOLECULAR CRYSTALS 2002
Document
IPR2018-00126, No. 2007-30 Exhibit - Joel Bernstein, POLYMORPHISM IN MOLECULAR CRYSTALS 2002 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2010 Exhibit: America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fu...
Document
IPR2018-00126, No. 2010-32 Exhibit - America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices, I MAK 2017 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2003 Exhibit: Jonathan D Rockoff, et al, FDA Approves Gilead¿¿¿s Hepatitis C Drug T...
Document
IPR2018-00126, No. 2003-26 Exhibit - Jonathan D Rockoff, et al, FDA Approves Gilead¿¿¿s Hepatitis C Drug THE WALL STREET JOURNAL, 2013 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2011 Exhibit: Our People, I MAK 2018
Document
IPR2018-00126, No. 2011-33 Exhibit - Our People, I MAK 2018 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2013 Exhibit: Guidance for Industry Q3C ¿¿¿ Tables and List, FDA Nov 2003
Document
IPR2018-00126, No. 2013-35 Exhibit - Guidance for Industry Q3C ¿¿¿ Tables and List, FDA Nov 2003 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2014 Exhibit: Kenneth R Morris, Structural Aspects of Hydrates and Solvates, in PO...
Document
IPR2018-00126, No. 2014-36 Exhibit - Kenneth R Morris, Structural Aspects of Hydrates and Solvates, in POLYMORPHISM IN PHARMACEUTICAL SOLIDS 125 181 Harry G Brittain ed 1999 (P...
|
|
Cite Document
2012 Exhibit: Stephen R Byrn et al, SOLID STATE PROPERTIES OF PHARMACEU...
Document
IPR2018-00126, No. 2012-34 Exhibit - Stephen R Byrn et al, SOLID STATE PROPERTIES OF PHARMACEUTICAL MATERIALS 1st ed 2017 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2009 Exhibit: Kowa Co v Amneal Pharm, Nos 14 cv 2758 PAC, 14 cv 7934 PAC, SD...
Document
IPR2018-00126, No. 2009-31 Exhibit - Kowa Co v Amneal Pharm, Nos 14 cv 2758 PAC, 14 cv 7934 PAC, SDNY Sept 19, 2017 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2006 Exhibit: Bruno C Hancock George Zografi, Characteristics and Significance o...
Document
IPR2018-00126, No. 2006-29 Exhibit - Bruno C Hancock George Zografi, Characteristics and Significance of the Amorphous State in Pharmaceutical Systems, 86 JOURNAL OF PHARMACEUTI...
|
|
Cite Document
2005 Exhibit: US Patent No 9,340,568
Document
IPR2018-00126, No. 2005-28 Exhibit - US Patent No 9,340,568 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2004 Exhibit: US Patent No 8,889,159
Document
IPR2018-00126, No. 2004-27 Exhibit - US Patent No 8,889,159 (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2015 Exhibit: Sherry L Morissette et al, High Throughput Crystallization Polymorph...
Document
IPR2018-00126, No. 2015-37 Exhibit - Sherry L Morissette et al, High Throughput Crystallization Polymorphs, Salts, Co Crystals and Solvates of Pharmaceutical Solids, 56 ADVANCED DRUG DE...
|
|
Cite Document
